Norwest's Biotechnology Portfolio

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.

SetPoint Medical provides a device-based therapy for rheumatoid arthritis.

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

Myome helps identify genes that cause disease and act based on leading science.

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

Ouroboros Medicines is a biotechnology company specializes in immunology.

Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.

Nueclear Healthcare is the low-cost cancer diagnosis services business of the Thyrocare group